title: [Treatment of migraine attacks].
abstract: The authors have presented a review of the main controlled studies on drug treatment for the management of migraine attacks: non-steroidal anti-inflammatory drugs (NSAIDs), rye ergot derivatives, and the recently commercialized triptan group of drugs. An overview is provided of their specific properties, indications and contraindications, and their respective use in the treatment of migraine headaches.
authors.affiliation: Service de médecine interne IV et centre migraine et céphalées, hôpital Louis-Mourier, Colombes, France.
authors.forename: A
authors.initials: A
authors.lastname: Pradalier
authors.forename: G
authors.initials: G
authors.lastname: Baudesson
authors.forename: A
authors.initials: A
authors.lastname: Delage
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004876:Ergot Alkaloids; D017366:Serotonin Receptor Agonists